Table 1. Comparison in gene expression level between normal and tumor tissues.
| Gene symbol | Gene title | Fold changea | Adjuste P-valueb |
| ANO1 | anoctamin 1, calcium activated chloride channel | 0.48 | 6.1×10−5 |
| CACNA1C | calcium channel, voltage-dependent, L type, alpha 1C subunit | 0.56 | 1.8×10−9 |
| CACNA1D | calcium channel, voltage-dependent, L type, alpha 1D subunit | 0.54 | 3.3×10−6 |
| CACNA2D2 | calcium channel, voltage-dependent, alpha 2/delta subunit 2 | 0.27 | 7.2×10−7 |
| CACNB3 | calcium channel, voltage-dependent, beta 3 subunit | 1.48 | 2.8×10−5 |
| CLCC1 | chloride channel CLIC-like 1 | 1.52 | 1.6×10−8 |
| CLCN3 | chloride channel, voltage-sensitive 3 | 1.39 | 5.7×10−4 |
| CLCN7 | chloride channel, voltage-sensitive 7 | 1.80 | 2.1×10−12 |
| CLIC3 | chloride intracellular channel 3 | 0.17 | 6.6×10−13 |
| CLIC4 | chloride intracellular channel 4 | 0.62 | 8.1×10−7 |
| CLIC5 | chloride intracellular channel 5 | 0.06 | 3.3×10−20 |
| CLIC6 | chloride intracellular channel 6 | 3.28 | 3.7×10−8 |
| KCNAB1 | potassium voltage-gated channel, shaker-related subfamily, beta member 1 | 0.26 | 2.1×10−12 |
| KCNAB2 | potassium voltage-gated channel, shaker-related subfamily, beta member 2 | 0.62 | 1.2×10−5 |
| KCNJ2 | potassium inwardly-rectifying channel, subfamily J, member 2 | 0.50 | 4.8×10−5 |
| KCNJ8 | potassium inwardly-rectifying channel, subfamily J, member 8 | 0.25 | 2.8×10−15 |
| KCNK1 | potassium channel, subfamily K, member 1 | 2.32 | 5.1×10−6 |
| KCNK3 | potassium channel, subfamily K, member 3 | 0.09 | 3.2×10−20 |
| KCNK5 | potassium channel, subfamily K, member 5 | 4.77 | 1.5×10−12 |
| KCNMB4 | potassium large conductance calcium-activated channel, subfamily M, beta member 4 | 0.24 | 4.3×10−8 |
| KCNQ3 | potassium voltage-gated channel, KQT-like subfamily, member 3 | 2.69 | 1.4×10−8 |
| KCNT2 | potassium channel, subfamily T, member 2 | 0.10 | 2.4×10−18 |
| MCOLN1 | mucolipin 1 | 0.72 | 6.2×10−5 |
| MCOLN2 | mucolipin 2 | 0.54 | 1.9×10−5 |
| MCOLN3 | mucolipin 3 | 0.29 | 6.4×10−9 |
| PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.69 | 1.6×10−7 |
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.64 | 1.7×10−5 |
| SCN4B | sodium channel, voltage-gated, type IV, beta subunit | 0.13 | 1.5×10−14 |
| SCN7A | sodium channel, voltage-gated, type VII, alpha subunit | 0.16 | 4.2×10−10 |
| SCNN1B | sodium channel, non-voltage-gated 1, beta subunit | 0.36 | 1.3×10−6 |
| SCNN1G | sodium channel, non-voltage-gated 1, gamma subunit | 0.20 | 6.0×10−10 |
| TPCN1 | two pore segment channel 1 | 0.76 | 7.8×10−4 |
| TRPC1 | transient receptor potential cation channel, subfamily C, member 1 | 0.49 | 5.3×10−8 |
| TRPC6 | transient receptor potential cation channel, subfamily C, member 6 | 0.31 | 4.6×10−9 |
| TRPM2 | transient receptor potential cation channel, subfamily M, member 2 | 1.53 | 1.2×10−5 |
| TRPV2 | transient receptor potential cation channel, subfamily V, member 2 | 0.34 | 1.2×10−13 |
| VDAC1 | voltage-dependent anion channel 1 | 1.36 | 6.1×10−5 |
a
Fold change is calculated by dividing the expression of tumor tissue by the expression of normal tissue.
b
P-value is calculated by paired t-test and adjusted by Benjamini & Hochberg correction.